TETI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 8.731
EU - Europa 5.968
AS - Asia 4.587
SA - Sud America 1.814
AF - Africa 121
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 21.238
Nazione #
US - Stati Uniti d'America 8.595
SG - Singapore 1.799
CN - Cina 1.647
BR - Brasile 1.631
IE - Irlanda 1.412
SE - Svezia 1.253
IT - Italia 654
DE - Germania 644
UA - Ucraina 552
HK - Hong Kong 539
FI - Finlandia 323
RU - Federazione Russa 236
GB - Regno Unito 230
PL - Polonia 219
FR - Francia 217
VN - Vietnam 204
IN - India 72
AR - Argentina 68
CA - Canada 54
CZ - Repubblica Ceca 52
BD - Bangladesh 51
BE - Belgio 48
MX - Messico 44
IQ - Iraq 38
ZA - Sudafrica 38
TR - Turchia 32
EC - Ecuador 31
MA - Marocco 29
UZ - Uzbekistan 27
JP - Giappone 23
PK - Pakistan 22
AT - Austria 21
CO - Colombia 21
ES - Italia 20
NL - Olanda 18
VE - Venezuela 17
ID - Indonesia 16
AE - Emirati Arabi Uniti 14
CL - Cile 13
TN - Tunisia 13
JO - Giordania 12
DO - Repubblica Dominicana 11
UY - Uruguay 11
EG - Egitto 10
AZ - Azerbaigian 9
BG - Bulgaria 9
DZ - Algeria 9
IR - Iran 9
NP - Nepal 9
PY - Paraguay 9
KE - Kenya 8
PE - Perù 8
AL - Albania 7
KZ - Kazakistan 7
LT - Lituania 7
PS - Palestinian Territory 7
RO - Romania 7
CH - Svizzera 6
EU - Europa 6
JM - Giamaica 6
KG - Kirghizistan 6
LV - Lettonia 6
OM - Oman 6
AM - Armenia 5
CR - Costa Rica 5
SN - Senegal 5
AU - Australia 4
BN - Brunei Darussalam 4
IL - Israele 4
LB - Libano 4
NZ - Nuova Zelanda 4
PA - Panama 4
PT - Portogallo 4
BO - Bolivia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
NO - Norvegia 3
SA - Arabia Saudita 3
TW - Taiwan 3
AO - Angola 2
CY - Cipro 2
EE - Estonia 2
GE - Georgia 2
GR - Grecia 2
GY - Guiana 2
KH - Cambogia 2
LK - Sri Lanka 2
MY - Malesia 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CG - Congo 1
Totale 21.222
Città #
Dublin 1.411
Dallas 1.214
Chandler 1.128
Jacksonville 1.120
Singapore 858
Ashburn 767
Nyköping 687
Hong Kong 537
Beijing 526
Shenzhen 449
Messina 287
Dearborn 249
Princeton 243
Cambridge 235
Medford 235
Los Angeles 232
Boardman 213
Warsaw 213
Des Moines 195
Ann Arbor 188
The Dalles 169
Buffalo 141
Munich 115
São Paulo 113
New York 107
Woodbridge 80
Bremen 70
Ho Chi Minh City 68
Shenyang 60
Wilmington 57
Moscow 56
Jinan 55
Tianjin 52
Belo Horizonte 49
Hanoi 49
Brussels 48
San Mateo 47
Brno 46
Helsinki 43
Redondo Beach 39
Turku 39
Rio de Janeiro 34
Nanjing 33
Pune 31
Brasília 30
Lancaster 30
Haikou 29
Nuremberg 29
Milan 27
Hebei 26
Santa Clara 26
Tashkent 26
Ningbo 25
Houston 24
Seattle 24
Dong Ket 23
Zhengzhou 23
Johannesburg 22
Norwalk 22
Rome 22
Brooklyn 21
Chennai 21
Curitiba 21
Düsseldorf 21
Tokyo 21
Council Bluffs 20
Frankfurt am Main 20
Montreal 19
Porto Alegre 18
Stockholm 18
Taiyuan 18
London 17
Campinas 16
Goiânia 16
Hangzhou 16
Ribeirão Preto 16
Taizhou 16
Guangzhou 15
Baghdad 14
Dhaka 14
Washington 14
Boston 13
Catania 13
Guarulhos 13
Poplar 13
Campo Grande 12
Chicago 12
Denver 12
Guayaquil 12
Orem 12
São José dos Campos 12
Vienna 12
Amman 11
Changsha 11
Montevideo 11
Nanchang 11
Quito 11
Salvador 11
San Francisco 11
Amsterdam 10
Totale 13.591
Nome #
Immunogenic Properties of Streptococcus agalactiae FbsA Fragments. 556
ATTIVAZIONE DI NLRP3 IMFLAMMASOMA NEL CORSO DELLE INFEZIONI SOSTENUTE DAGLI STREPTOCOCCHI DI GRUPPO B 214
Neutrophils Directly Recognize Group B Streptococci and Contribute to Interleukin-1β Production during Infection. 183
Functional characterization of a monoclonal antibody epitope using a lambda phage display-deep sequencing platform 167
The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci 165
Phage display revisited: Epitope mapping of a monoclonal antibody directed against Neisseria meningitidis adhesin A using the PROFILER technology 163
Antiidiotypic DNA vaccination induces serum bactericidal activity and protection against group B meningococci 156
Analysis of the secretome of the group B Streptococcus 154
Anti-idiotypic B5 single chain variable fragment [synthetic construct]. 148
A new surface protein of Streptococcus suis identified by proteomics 144
beta(2) integrins are involved in cytokine responses to whole Gram-positive bacteria 142
Anti-idiotypic G1 single chain variable fragment [synthetic construct]. 142
A surface protein of Streptococcus suis serotype 2 identified by proteomics protects mice against infection 142
Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor 137
Characterization of two novel Cryptococcal mannoproteins recognized by immune sera 136
Approccio proteomico per l’analisi comparativa del secretoma di coltura di S. agalactiae, ceppo Nem316 135
Activation of the NLRP3 inflammasome by group B streptococci. 134
Analysis of the Streptococcus agalactiae exoproteome. 134
Caratterizzazione molecolare di glicoproteine criptococciche capaci di indurre risposte umorali. 132
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection. 132
Epitope mapping of a monoclonal antibody directed against neisserial heparin binding antigen using next generation sequencing of antigen-specific libraries 130
Bacteroides fragilis lipopolysaccharide activates cells via CD14/MD2/TLR4 123
PbsP, a cell wall-anchored protein that binds plasminogen to promote hematogenous dissemination of Group B Streptococcus 123
“Antibody killing of Candida albicans after immunization with peptides mimicking a killer toxin receptor” 121
Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4 121
Anti-idiotypic vaccination against group B streptococci 120
MyD88 and TLR2, but not TLR4, are required for host defense against Cryptococcus neoformans 120
Age-related sensitivity of neonatal mice to toxicity induced by heat-killed group B streptococci. 119
CXCL1/2 chemokines are newly synthesized by neutrophils and released at high levels after recognition of live Group B Streptococcus by means of endosomal Toll-like receptors 119
The Streptococcus agalactiae cell wall-anchored protein PbsP mediates adhesion to and invasion of epithelial cells by exploiting the host vitronectin/αvintegrin axis 118
Attivazione dell'inflammasoma da parte di S.pneumoniae 117
Costruzione e screening di librerie “lambda display” da genoma completo di streptococchi patogeni per l’identificazione di prodotti genici che interagiscono con i tessuti dell’ospite. 116
Recognition of Neisseria meningitidis by the Long Pentraxin PTX3 and Its Role as an Endogenous Adjuvant 115
Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease 115
Peptide mimics of the group B meningococcal capsule induce bactericidal and protective antibodies after immunization 115
La proteina FbsA di Streptococcus agalactiae è unimportante fattore di virulenza 115
VACCINE FORMULATIONS COMPRISING ANTIIDIOTYPIC ANTIBODIES WHICH IMMUNOLOGICALLY MIMIC GROUP B STREPTOCOCCAL CARBOHYDRATES 114
Neonatal mouse immunity against group B streptococcal infection by maternal vaccination with recombinant anti-idiotypes 114
Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria 114
A meeting of mimics. 113
AGE-RELATED MORTALITY AND ADHERENT SPLENIC CELL MEDIATOR PRODUCTION TO ENDOTOXIN IN THE RAT 112
The Phagocyte, Metchnikoff, and the Foundation of Immunology 112
NEUTROPHILS PRODUCE HIGH LEVELS OF CHEMOKINES (CXCL1/2) AFTER SENSING GROUP B STREPTOCOCCUS THROUGH ENDOSOMAL TLRS 112
Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection 111
Protective Activity of Streptococcus pneumoniae Spr1875 Protein Fragments Identified Using a Phage Displayed Genomic Library. 111
Immunogenic mimics of Brucella lipopolysaccharide epitopes 110
Protective activity of a protein fragment identified by the screening of a Streptococcus pneumoniae phage-displayed genomic library 110
Yeast Killer Toxin-Like Candidacidal Ab6 Antibodies Elicited through the Manipulation of the Idiotypic Cascade 110
Neutrophils Enhance Their Own Influx to Sites of Bacterial Infection via Endosomal TLR-Dependent Cxcl2 Production 110
The dual role of innate immunity during influenza 109
CELL ACTIVATION INDUCED BY LIPOTEICHOIC ACID AND POLYSACCHARAIDES FRM STREPTOCOCCI. 108
ANTI-LIPOTEICHOIC ACID ANTIBODIES ENHANCE RELEASE OF CYTOKINES BY MONOCYTES SENSITIZED WITH LIPOTEICHOIC ACID 108
Evaluation of a rapid method to exclude the presence of certain enteric pathogens in stool specimens. 108
Essential role of interleukin-1 signaling in host defenses against group B streptococcus 108
Identificazione mediante “Phage Display” diframmenti biologicamente attivi della fibrinogenbinding protein A (FbsA) di Streptococcus agalactiae. 107
Rapid Profiling of the Antigen Regions Recognized by Serum Antibodies Using Massively Parallel Sequencing of Antigen- Specific Libraries 107
Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells 105
Role of gamma interferon in a neonatal mouse model of group B streptococcal disease 104
Immunoprotective activity of a Streptococcus pneumoniae protein identified by phage display. 104
NEUTROPHILS ARE MAINLY RESPONSIBLE FOR IL-1Β PRODUCTION DURING GROUP B STREPTOCOCCUS INFECTION 104
The IL-1b/CXCL1/2/neutrophil axis mediates host protection against group B streptococcal infection 103
Neutrophils discriminate live from dead bacteria by integrating signals initiated by Fprs and TLRs 102
Vaccinazione anti-idiotipica a DNA per l'induzione di anticorpi diretti contro il polissacaride di batteri capsulati. 101
Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells 101
Plasminogen- and Fibronectin–Binding Protein B Is Involved in the Adherence of Streptococcus pneumoniae to Human Epithelial Cells. 101
Adherence of group B streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. 101
BETA-LACTAM ANTIBIOTICS (AZTREONAM, AMPICILLIN, CEFAZOLIN AND CEFTAZIDIME) IN THE CONTROL AND ERADICATION OF SALMONELLA- TYPHIMURIUM IN NATURALLY RESISTANT AND SUSCEPTIBLE MICE 100
Interleukin-6 production by human monocytes stimulated with Cryptococcus neoformans components 100
Proceedings of the second Centro 3R Annual Meeting | September 30th - October 1st of Biomedical Science and Engineering. Vol. 4 No. s1 (2021) 100
Ruolo dell'interluchina 18 nelle infezioni da streptococco di gruppo B. 99
Risposta dell'Ospite alle Infezioni Batteriche 99
Prevention of endotoxin-induced lethality in neonatal mice by interleukin-13 99
Effects of taxol on TNF-alpha and IL-6 production by human peripheral blood cells. 98
Effects of anti-cytokine treatments in neonatal sepsis models 97
Uso del “phage display”per caratterizzare ilrepertorio anticorpale indotto da vaccinazione. 97
Isolation of bacterial RNA from infected host tissues: application for transcriptomic studies of group B streptococci 97
Induction of T helper type 1 responses by a polysaccharide deacetylase from Cryptococcus neoformans 96
Virus ed infezioni alimentari: il caso dell’epatite A 96
Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice 96
Immunità protettiva indotta da una glutamina sintetasi di Cryptococcus neoformans 95
Compositional analysis of the major capsular polysaccharides of Cryptococcus neoformans by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) 95
Identification and cloning of a cryptococcal deacetylase that produces protective immune responses 94
Selection of Neisseria meningitidis group B antigenic epitopes using lambda libraries. 94
Cross reattività di una lipoproteina di Neisseriameningitidis con la proteina legante il fattore H (fHbp) 94
Role of TLR13 in innate immune recognition of group B streptococci 94
L'IFN-beta è fondamentale nel polarizzare la risposta citochinica verso il tipo 1 nel corso dell'infezione da cryptococcus neoformans. 93
IFN-alpha/beta signaling is required for polarization of cytokine responses toward a protective type I pattern during experimental cryptococcosis 92
Vaccinazione anti-idiotipica nei confronti di infezioni sperimsntali da Neisseria meningitidis di gruppo B con anticorpi ricombinanti immagini interne del polissacaride capsulare. 91
Brucellosi:Aspetti medici e sociali 91
The Mannoprotein Cig1 supports iron acquisition from heme and virulence in the pathogenic fungus Cryptococcus neoformans. 91
G(i) proteins regulate lipopolysaccharide and Staphylococcus aureus induced cytokine production but not (1 -> 3)-beta-D-glucan induced cytokine suppression 90
Recognition of yeast nucleic acids triggers a host-protective type I interferon response 90
Therapy of mucosal candidiasis by expression of an anti- idiotype in human commensal bacteria 89
Combating antibiotic resistance in S. pneumoniae infections: identification of pneumolysin binding peptides 89
Plasminogen binding and immunoprotective properties of the Mk-rich domain of PbsP, a cell wall protein from Streptococcus agalactiae 89
Role of host's immune response in infections caused by Streptococcus pneumoniae 89
BENEFICIAL-EFFECTS OF INTERLEUKIN-6 IN NEONATAL MOUSE MODELS OF GROUP-B STREPTOCOCCAL DISEASE 88
Plasminogen- and fibronectin–binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cell 88
[Genetic techniques for the production of influenza vaccines (author's transl)]. 88
Pro-interleukin-1 beta processing in response to streptococci is totally caspase-1 dependent in vitro, but not in vivo. 88
Totale 11.743
Categoria #
all - tutte 78.651
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.651


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021918 0 0 0 0 0 219 45 146 79 199 139 91
2021/20221.600 18 259 16 34 37 11 114 76 17 192 288 538
2022/20234.266 341 348 178 388 412 408 58 243 1.712 19 115 44
2023/20241.456 86 159 526 86 105 212 7 58 2 33 16 166
2024/20254.594 79 53 81 289 140 161 89 1.123 1.191 258 367 763
2025/20264.419 550 885 1.098 717 1.070 99 0 0 0 0 0 0
Totale 21.419